Searchable abstracts of presentations at key conferences in endocrinology

ea0019p102 | Clinical practice/governance and case reports | SFEBES2009

Propylthiouracil-induced antineutrophilic cytoplasmic antibody-positive vasculitis

Bravis V , Kong C , Johnston C

A 38-year old lady from the Philippines presented with a 2-year history of a painless thyroid lump, without pressure symptoms. Over the previous year it had gradually enlarged in size. She gave a history of disturbed sleep, tremor, anxiety and weight loss over the 2-year period. Past medical history included right middle lobectomy for bronchiectasis 10 years previously. Thyroid function tests revealed TSH<0.05 mu/l, FT4 86 pmol/l, FT3 18.3 pmol/l and ...

ea0007p259 | Clinical case reports | BES2004

Diagnostic difficulty in differentiating between meningioma and pituitary adenoma

Hatfield E , Lewis D , Powell M , Ng K , Kong C , Johnston C

We report two patients (AB 41 years, LS 55 years) presenting with symptoms of hyperprolactinaemia. Prolactin levels were moderately elevated: 1539 (AB), 1186 (LS) (NR 59-619 mU/L). The remainder of the pituitary profile was normal. Neither patient had visual field defects. MRIs (without contrast) reported pituitary macroadenoma with suprasellar extension but no optic chiasm compression. The initial diagnosis was of probable non-functioning adenoma causing stalk compression. Bo...

ea0005p59 | Clinical Case Reports | BES2003

Calcitonin in nodular thyroid disease

Patel D , Johnston C

Sporadic Medullary thyroid carcinoma (MTC) is an uncommon thyroid cancer. The prevalence has been studied in two large European studies(1,2). Serum calcitonin provides a highly sensitive and specific tumour marker for this. We shall present a case which typifies the presentation of MTC and discuss its relevance.A 71-year-old gentleman of Italian descent was admitted in 2001 with left lower limb cellulitis. It was documented that he had an incidental goitre, that had been p...

ea0004p19 | Clinical case reports | SFE2002

Lithium and Parathyroid Dysfuction

Patel D , Johnston C , Farid N

Lithium-induced hyperparathyroidism was first described in 1973 by Garfinkel et. al.The two cases aim to illustrate Lithium-induced hyperparathyroidism which was previously thought to be a rare occurrence and outline characteristic features of this disorder.Case 1.A 51 year old male presented with polydipsia and polyuria. He was known to suffer from bipolar affective disorder with lithium treatment was admitt...

ea0004dp24 | Diabetes, metabolism and cardiovascular | SFE2002

Lithium and Parathyroid Dysfuction

Patel D , Johnston C , Farid N

Lithium-induced hyperparathyroidism was first described in 1973 by Garfinkel et. al.The two cases aim to illustrate Lithium-induced hyperparathyroidism which was previously thought to be a rare occurrence and outline characteristic features of this disorder.Case 1.A 51 year old male presented with polydipsia and polyuria. He was known to suffer from bipolar affective disorder with lithium treatment was admitt...

ea0050p338 | Obesity and Metabolism | SFEBES2017

Body fat distribution by dual energy x-ray absorptiometry (DXA) and metabolic risk factors in intravenous glucose tolerance test (IVGTT)-defined high and low insulin sensitivity normoglycaemic, overweight men

Loh Wann Jia , Stevenson John C , Johnston Desmond G , Godsland Ian F

Background: Increased adiposity is associated with increased cardiovascular disease (CVD) risk but among overweight individuals clarification is needed of relationships between insulin sensitivity, fat distribution and metabolic health that might contribute to this risk.Methods: During the Heart Disease and Diabetes Research Indicators in a Screened Cohort (HDDRISC) study, 560 employment cohort normoglycaemic (FPG less than 7...

ea0050p338 | Obesity and Metabolism | SFEBES2017

Body fat distribution by dual energy x-ray absorptiometry (DXA) and metabolic risk factors in intravenous glucose tolerance test (IVGTT)-defined high and low insulin sensitivity normoglycaemic, overweight men

Loh Wann Jia , Stevenson John C , Johnston Desmond G , Godsland Ian F

Background: Increased adiposity is associated with increased cardiovascular disease (CVD) risk but among overweight individuals clarification is needed of relationships between insulin sensitivity, fat distribution and metabolic health that might contribute to this risk.Methods: During the Heart Disease and Diabetes Research Indicators in a Screened Cohort (HDDRISC) study, 560 employment cohort normoglycaemic (FPG less than 7...

ea0019p103 | Clinical practice/governance and case reports | SFEBES2009

Idiopathic urticaria and angioedema in a patient with autoimmune thyrotoxicosis

Bravis V , Shah N , Dear J , Davey S , Johnston C , Kong C

A 29-year-old lady with known autoimmune thyrotoxicosis (TPO 712 IU/ml) presented with an urticarial rash. She was on carbimazole. A diagnosis of drug-induced reaction was suspected and treated as such. Her carbimazole was discontinued. After a day of treatment with steroids and antihistamines, she experienced flushing, orthostatic hypotension and difficulty in breathing. She was treated for anaphylaxis with adrenaline on intensive care unit. A formal Dermatology opinion was p...

ea0004p36 | Diabetes, metabolism and cardiovascular | SFE2002

CONSEQUENCES OF PREVIOUS GESTATIONAL DIABETES ON ASPECTS OF THE METABOLIC SYNDROME

Kousta E , Efstathiadou Z , Lawrence N , Barrett S , Dore C , Johnston D , McCarthy M

We investigated the relationship between gestational diabetes (GDM) and the metabolic syndrome in 368 (185 European (EUR), 103 South Asian (SA) and 80 Afro-Caribbean (AC)) women studied 20.0 (18.2-22.1) months (mean (95% CI)) following a GDM pregnancy and 482 normoglycaemic women (288 EUR, 99 SA, 95 AC) with no history of GDM. Estimates of beta-cell function (%B) and insulin sensitivity (%S) were derived using the HOMA method. Analysis was by multiple linear regression includi...

ea0010p28 | Diabetes, metabolism and cardiovascular | SFE2005

Ghrelin enhances gastric emptying in diabetic gastroparesis

Murray C , Martin N , Patterson M , Taylor S , Ghatei M , Kamm M , Johnston C , Bloom S , Emmanuel A

Background: Diabetic gastroparesis is a disabling condition with no consistently effective treatment. Ghrelin infusion, in animal studies, increases gastric emptying and reverses post-operative ileus. We present the results of the first double-blind placebo-controlled cross-over study of ghrelin in gastric emptying in patients with diabetic gastroparesis....